Elanco Animal Health Inc has reported a transaction involving deferred stock units by its Chief Financial Officer, Robert M. VanHimbergen. This move, documented in a recent SEC filing, highlights the company's ongoing strategies to align executive compensation with shareholder interests.
Elanco, a prominent player in the pharmaceutical preparations sector, focuses on animal health products and services. The company trades under the ticker ELAN on the New York Stock Exchange and is classified under the Standard Industrial Classification code 2834.
What the Filing Says
According to the filing dated October 20, 2026, VanHimbergen acquired 8.366 deferred stock units on October 16, 2026, at a price of $23.55 per share. Following this transaction, he now holds a total of 175.9183 shares. Each deferred stock unit represents the right to receive one share of common stock or the cash equivalent.
Impact
This transaction may affect Elanco's executive compensation landscape, showcasing how the company is incentivizing its leadership. Such actions can influence investor perceptions and may prompt similar strategies among competitors in the pharmaceutical preparations industry.
What's Next
The filing does not say what happens next.
Details of the Transaction
The deferred stock units acquired by VanHimbergen are part of the company's Executive Deferral and Stock Match Plan. This plan allows for the settlement of deferred stock units in cash or shares of common stock following the termination of employment or during a specified future year.
About the Executive
Robert M. VanHimbergen serves as the Executive Vice President and Chief Financial Officer of Elanco Animal Health Inc. His role is crucial in overseeing the financial operations of the company, ensuring that financial strategies align with the overall business objectives.
Company Overview
Elanco Animal Health Inc, with a fiscal year ending on December 31, is headquartered in Indianapolis, Indiana. The company is dedicated to providing innovative solutions for animal health, focusing on the needs of both livestock and companion animals.
Additional Context
The filing does not include information about other recent transactions by Elanco executives or any potential future plans for additional stock unit grants.